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ABSTRACT
Objective: This study was designed to determine the effect of the combination of some natural compounds with ciprofloxacin (CIP) against methicillin-
resistant Staphylococcus aureus (MRSA) strains.
Methods: About 15 (MRSA) strains were selected of patients suffer from different infections. Natural compounds included flavonoids rutin, quercetin, 
polyphenolic acids gallic acid, tannic acid, and phenylpropanoids such as 4-hydroxy coumarin, thymol, caffeine, and ethyl cinnamate were applied 
alone and in combination with CIP.
Results: Most natural products showed activity against MRSA strains when tested alone. The combination was decreased the activity of CIP. Quercetin 
and tannic acid were the most effective compounds, but rutin, gallic acid, 4-hydroxy comarine, thymol, and caffeine had no activity against (MRSA) 
strains.
Conclusion: The relationship between the natural compounds and CIP was antagonism, wherein the compounds had reduced the antibacterial effects 
of CIP in combination.
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INTRODUCTION
Staphylococcus aureus is a Gram-positive, coagulase positive coccus 
in the family Staphylococcaceae, found on the mucus membranes and 
the human skin [1]. A number of strains have developed resistance to 
more than 20 other antimicrobial drugs which they represent more 
than 60% of S. aureus isolates, and they are classified as methicillin-
resistant S. aureus (MRSA). They are an opportunist strains because 
they have acquired a gene that makes them resistant to all beta-lactam 
antibiotics [2-4]. They can cause various invasive conditions such as 
pneumonia, endocarditis, septic arthritis, osteomyelitis, meningitis, 
septicemia, and nosocomial infections associated with indwelling 
medical devices and surgical sites [5]. Human community-acquired-
MRSA strains are mainly associated with superficial skin or soft tissue 
disease, although they have also caused sepsis, necrotizing fasciitis, 
necrotizing pneumonia, and other conditions [6,7]. The morbidity 
and mortality associated with MRSA infections is high in spite of 
antimicrobial therapy. Therefore, the search for new structural ligands 
and novel targets of attack as a means to overcome bacterial resistance 
is an important research goal [8]. Combination therapy is a new way, 
which may improve the efficacy of antimicrobial treatment for resistant 
microbes [9]. Most recent studies showed that natural compounds have 
been explored a strong antimicrobial activity against Gram-positive 
bacteria when they were used in combination with antibiotics [10].
Natural compounds are chemical compounds or substances produced 
by a living organism such as plants, animals, or bacteria and fungi [11]. 
There are various chemical components with antimicrobial effect 
including saponins, flavonoids, thiosulfinates, glucosinolates, phenolics, 
and organic acids [12]. The antimicrobial efficacy of components in 
plants depends on the chemical structure of active components and their 
concentration [13]. However, phenolic compounds such as terpenes, 
aliphatic alcohols, aldehydes, ketones, acids, and isoflavonoids are the 
main components in plants with antimicrobial activity. Flavonoids such 
as myricetin, rutin, kaempferol, quercetin and flavones such as luteolin 
have inhibited the growth of MRSA. Furthermore, alkyl gallates (methyl, 
ethyl, propyl, and butyl gallates) and gallic acid, phenylpropanoids such 
as 3,4-dimethoxycinnamic, ethyl cinnamate, 2,4,5-trimethoxycinnamic 
acid, 4-hydroxy coumarin, caffeine, chlorogenic, ferulic acids constitute 
a large part of our daily diet and there is a possibility that they may act 
as antibacterial agents [14,15].
The combination of natural compounds with antibiotics may be 
appeared as synergistic, additive, or antagonistic type. Most of the 
antibiotics in combination with natural compounds have a synergistic 
activity, but some antibacterial agents have antagonistic effects [16]. 
The compound (ciprofloxacin [CIP]), a fluoroquinolone compound, 
has a good antibacterial activity on dangerous infections. It is used 
commonly in the treatment of many infections especially urinary tract 
infections, sexually transmitted diseases, respiratory infections, and 
gastrointestinal infections [17]. The combination of CIP with antibiotics 




About 15 clinical strains were collected from patients of Aleppo 
University Hospital.
Bacterial culturing medias such as nutrient agar (NA; CM0003B), Muller 
Hinton agar (MHA; CM0337B), were from Oxoid, UK. Mannitol salt agar 
(MSA; LAB007) was obtained from Lab M Limited, UK.
Isolates identification were performed using Gram-staining, catalase 
test, coagulase test, and MSA differentiation [19].
Isolated colonies of S. aureus from MSA plates were aseptically 
inoculated in sterile nutrient broth and incubated overnight at 37°C. 
Thereafter, turbidity of inoculum was adjusted to 0.5 McFarland using 
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0.9% (w/v) sterile normal saline and was used to prepare bacterial 
lawns on sterile MHA plates. Methicillin discs were applied on seeded 
plates and incubated overnight at 37±1°C. Following incubation, plates 
with zones of inhibitions <10 mm diameter or no zone of inhibition 
were considered to be MRSA strains [20].
Natural compounds
Different natural compounds, Table 1, were used in combination with 
standard CIP (Sigma-Aldrich, UK). Stock solutions of the compounds 
made at concentrations of 6 g/l by dissolving the powder in 
dimethylsulfoxide. CIP solution was prepared at concentration 0.05 g/l.
Natural compounds and CIP sensitivity tests
Susceptibility tests of clinical strains to CIP, natural compounds, 
and CIP+natural compounds combinations were tested using well 
diffusion method on MHA plates [21]. Every well was injected with 
500 µg/100 µl, and in the combination, it was 500 µg/50 µl of every 
natural compound with 5 µg/50 µl of CIP. Following overnight 
incubation at 37°C diameters of inhibition zones were recorded. Test 
substances were considered to have activity if diameter of inhibition 
zone was >10 mm, whereas ≤10 mm zone of inhibition were regarded 
as inactive [22].
RESULTS
The studied compounds showed different activity against the MRSA 
strains. Some natural compounds had antibacterial effects when were 
applied alone. Quercetin and tannic acid had the best activity compound 
against the MRSA strains and the diameter of inhibition zones ranged 
from 20 to 25 mm of quercetin and ranged from 20 to 22 mm of tannic 
acid. Rutin, ethyl cinnamate, caffeine, gallic acid, and thymol had no 
activity at all. 4-hydroxy coumarin had no activity against some MRSA 
strains but showed activity against other MRSA strains. Table 2 showed 
the diameters of inhibition zones of the compound CIP and natural 
compounds alone.
The results of the combination of natural compounds with CIP showed 
antibacterial activity against most MRSA strains, but the natural 
studied compounds had decreased the activity of CIP. Quercetin and 
CIP combination led to reduce the inhibition zone from 30 to 25 mm. 
Furthermore, tannic acid decreased the diameter of inhibition 
zone to 25 mm. Gallic acid, rutin, thymol, caffein, ethyl cinnamate had no 
effect on CIP in the combination. 4-hydroxy coumarin with CIP showed 
activity against some strains. Table 3 represented the diameters of 
inhibition zones of the combination of CIP with natural compounds.
DISCUSSION
The search for new antibacterial compounds become popular with the 
spread of multidrug-resistant bacteria, and less antibiotics are effective 
to counteract those bacteria including multidrug MRSA. Natural 
compounds have been proposed as alternative drugs because of their 
antibacterial effects. Moreover, natural compounds have been reported 
as drug modulating or modifying agents when they are given together 
with other drugs [23]. Natural compounds have different mechanisms 
Table 1: Natural compounds
Natural compounds Chemical group Source
Quercetin Flavonoid Sigma-Aldrich, UK
Rutin Flavonoid Sigma-Aldrich, UK
4-hydroxy coumarin Phenylpropanoid Himedia (India)
Tannic acid Phenolic acids Himedia (India)
Gallic acid Phenolic acids SRL
Thymol Phenylpropanoid SRL
Caffeine Alkaloid Himedia (India)
Eythyl cinnamate Phenylpropanoid Himedia (India)
Table 2: Diameters of inhibition zones (in mm) of natural 
compounds alone and CIP against MRSA strain
MRSA 
isolates
Natural compounds and CIP
Q R T G HQ TH CA EC CIP
1 25 Ne* 22 Ne* Ne* Ne* Ne* Ne* 30
2 22 Ne* 22 Ne* 25 Ne* Ne* Ne* 30
3 22 Ne* 22 Ne* 22 Ne* Ne* Ne* 28
4 22 Ne* 21 Ne* 20 Ne* Ne* Ne* 29
5 22 Ne* 22 Ne* Ne* Ne* Ne* Ne* 30
6 20 Ne* 20 Ne* Ne* Ne* Ne* Ne* 27
7 20 Ne* 20 Ne* Ne* Ne* Ne* Ne* 26
8 20 Ne* 22 Ne* Ne* Ne* Ne* Ne* 29
9 20 Ne* 20 Ne* Ne* Ne* Ne* Ne* 28
10 20 Ne* 21 Ne* Ne* Ne* Ne* Ne* 27
11 20 Ne* 21 Ne* Ne* Ne* Ne* Ne* 30
12 22 Ne* 20 Ne* 11 Ne* Ne* Ne* Ne*
13 23 18 22 Ne* 15 Ne* Ne* Ne* Ne*
14 23 Ne* 20 Ne* 15 Ne* Ne* Ne* Ne*
15 20 Ne* 20 Ne* 20 Ne* Ne* Ne* Ne*
Ne*: Negative result, Q: Quercetin, R: Rutin, G: Gallic acid, HQ: 4-hydroxy 
coumarin, TH: Thymol, CA: Caffeine, EC: Eythylcinnamate, CIP: Ciprofloxacin, 
MRSA: Methicillin-resistant Staphylococcus aureus
Table 3: Diameters of inhibition zones (in mm) of natural compounds in combination with CIP against MRSA
MRSA 
isolates

























1 25 30 25 30 Ne* 30 29 30
2 30 30 25 28 25 29 30 30
3 28 28 25 28 22 28 28 28
4 25 28 25 28 20 29 29 29
5 28 28 22 28 Ne* 30 30 30
6 25 25 22 25 Ne* 27 27 27
7 25 25 25 25 Ne* 26 26 26
8 25 28 21 28 Ne* 29 29 28
9 25 25 20 25 Ne* 28 28 28
10 25 25 22 25 Ne* 27 27 27
11 25 25 25 28 Ne* 30 30 29
12 22 Ne* 20 Ne* 11 Ne* Ne* Ne*
13 22 Ne* 18 Ne* 15 Ne* Ne* Ne*
14 20 Ne* 18 Ne* 15 Ne* Ne* Ne*
15 20 Ne* 20 Ne* 20 Ne* Ne* Ne*
Ne*: Negative result, Q: Quercetin, R: Rutin, G: Gallic acid, HQ: 4-hydroxy coumarin, TH: Thymol, CA: Caffeine, EC: Eythylcinnamate, CIP: Ciprofloxacin, 
MRSA: Methicillin-resistant Staphylococcus aureus
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of action as antibacterial agents. Flavonoids act in many ways to inhibit 
bacteria. Quercetin has been identified as topoisomerase Type II as 
CIP, so there is a competition between this two compounds on the 
goal enzyme [24]. The combination of CIP and quercetin led to reduce 
the antibacterial activity of CIP. Tannic acid achieves the antibacterial 
effect, mainly targeting on bacterial cell wall such as complex with cell 
wall protein, membrane disruption metal ion complexation, and binds 
to adhesions. However, the specific mechanism of tannic acid how it 
works together with antibiotics is still needed to be approved [25]. 
The present results revealed that the CIP activity was decreased in 
combination with tannic acid. There is a suggestion that tannic acid 
modulates the over activity of efflux pumps in MRSA strains, so it affects 
on CIP and causes to decrease its activity. Other natural compounds had 
no antibacterial activity, so there was no influence on the activity of CIP.
In this study, it was found that the combination of CIP with natural 
compounds could decrease the antibacterial activity against MRSA 
strains. Therefore, combination CIP with natural compounds should be 
taken in consideration.
The present research was limited to in-vitro studies only because of 
nonavailability of animal models facilities, which remained the major 
limitation of these studies. Since the findings are promising, therefore, 
they can be extended to in-vivo stage.
CONCLUSION
From the antibiotic sensitivity tests, it is evident that natural 
compounds quercetin, and tannic acid had an antibacterial effect, but 
gallic acid, 4-hydroxy coumarin, thymol, caffeine, and ethyl cinnamate 
had no inhibition effect against MRSA strains. Some natural compounds 
decreased the antibacterial activity of CIP. Antagonism effect showed 
between CIP and natural compounds in combination.
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